THE POTENTIAL OF CHIMERIC ANTIGEN RECEPTOR T CELL (CART-T CELL) TARGETTING PROSTATE-SPECIFIC MEMRANE ANTIGEN (PSMA) MODIFIED BY CRISPR/CAS9 AS PROSTATE CANCER THERAPY. JIMKI [Internet]. 2021 Jul. 12 [cited 2026 May 30];9(1):23-37. Available from: https://jimki.bapin.or.id/main/article/view/321